Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells

In allogeneic hematopoietic stem cell transplantation, donor αβ T cells attack recipient tissues, causing graft-versus-host disease (GVHD), a major cause of morbidity and mortality. A central question has been how GVHD is sustained despite T cell exhaustion from chronic antigen stimulation. The curr...

Full description

Saved in:
Bibliographic Details
Main Authors: Sacirbegovic, Faruk (Author) , Günther, Matthias (Author) , Greco, Alessandro (Author) , Zhao, Daqiang (Author) , Wang, Xi (Author) , Zhou, Meng (Author) , Rosenberger, Sarah (Author) , Oberbarnscheidt, Martin H. (Author) , Held, Werner (Author) , McNiff, Jennifer (Author) , Jain, Dhanpat (Author) , Höfer, Thomas (Author) , Shlomchik, Warren D. (Author)
Format: Article (Journal)
Language:English
Published: 14 February 2023
In: Immunity
Year: 2023, Volume: 56, Issue: 2, Pages: 369-385, e1-e6
ISSN:1097-4180
DOI:10.1016/j.immuni.2023.01.003
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.immuni.2023.01.003
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1074761323000134
Get full text
Author Notes:Faruk Sacirbegovic, Matthias Günther, Alessandro Greco, Daqiang Zhao, Xi Wang, Meng Zhou, Sarah Rosenberger, Martin H. Oberbarnscheidt, Werner Held, Jennifer McNiff, Dhanpat Jain, Thomas Höfer, and Warren D. Shlomchik
Description
Summary:In allogeneic hematopoietic stem cell transplantation, donor αβ T cells attack recipient tissues, causing graft-versus-host disease (GVHD), a major cause of morbidity and mortality. A central question has been how GVHD is sustained despite T cell exhaustion from chronic antigen stimulation. The current model for GVHD holds that disease is maintained through the continued recruitment of alloreactive effectors from blood into affected tissues. Here, we show, using multiple approaches including parabiosis of mice with GVHD, that GVHD is instead primarily maintained locally within diseased tissues. By tracking 1,203 alloreactive T cell clones, we fitted a mathematical model predicting that within each tissue a small number of progenitor T cells maintain a larger effector pool. Consistent with this, we identified a tissue-resident TCF-1+ subpopulation that preferentially engrafted, expanded, and differentiated into effectors upon adoptive transfer. These results suggest that therapies targeting affected tissues and progenitor T cells within them would be effective.
Item Description:Online verfügbar 30 January 2023, Version des Artikels 14 February 2023
Gesehen am 10.04.2024
Physical Description:Online Resource
ISSN:1097-4180
DOI:10.1016/j.immuni.2023.01.003